Profits and Promotion Under Attack

Wechsler,Jill;

Article

Pharmaceutical Executive

September 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive-09-01-2001

Volume0

Issue 0

Profits and Promotion Under Attack

Author(s):

Jill Wechsler, Pharm Exec’s Washington Correspondent

As policy makers struggle to devise a pharmacy benefit for Medicare patients, pressure mounts to impose spending limits on medications. In turn, consumer activists are challenging industry’s longtime claim that price controls will reduce investment in R&D for life-saving therapies.

Articles in this issue

Profits and Promotion Under Attack

New Playing Fields

Inefficiencies: Cutting Through the Jungle

Legislation: EC Proposes Changes

Flexing Their Budgets: Big Pharma Spend Trends

Media Mix Town Meeting 2001: Much Ado About Media

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Profits and Promotion Under Attack

Newsletter